Accordingly, patients with tumor cells expressing high levels of C/EBPδ show a significantly longer survival and a lower likelihood of lymph node involvement, i.e., presence of tumor cells in sentinel and surrounding lymph nodes, than patients whose primary tumor cells express low levels of C/EBPδ [15]. The gene discussed is CEBPD; the disease is neoplasm.